Friday, May 24, 2013

Jennerex Biotherapeutics Gets $21.6M

San Francisco-based Jennerex Biotherapeutics has raised $21.6M in funding, the firm announced Thursday. Source of the private placement was not disclosed. Jennerex is developing oncolytic immunotherapies for solid tumors. The company said the funds will be used to advance the clinical development of its lead product candidate. More information »